HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired activity of CCA-adding enzyme TRNT1 impacts OXPHOS complexes and cellular respiration in SIFD patient-derived fibroblasts.

AbstractBACKGROUND:
SIFD (Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay) is a novel form of congenital sideroblastic anemia associated with B-cell immunodeficiency, periodic fevers, and developmental delay caused by mutations in the CCA-adding enzyme TRNT1, but the precise molecular pathophysiology is not known.
RESULTS:
We show that the disease causing mutations in patient-derived fibroblasts do not affect subcellular localization of TRNT1 and show no gross morphological differences when compared to control cells. Analysis of cellular respiration and oxidative phosphorylation (OXPHOS) complexes demonstrates that both basal and maximal respiration rates are decreased in patient cells, which may be attributed to an observed decrease in the abundance of select proteins of the OXPHOS complexes.
CONCLUSIONS:
Our data provides further insight into cellular pathophysiology of SIFD.
AuthorsUrszula Liwak-Muir, Hapsatou Mamady, Turaya Naas, Quinlan Wylie, Skye McBride, Matthew Lines, Jean Michaud, Stephen D Baird, Pranesh K Chakraborty, Martin Holcik
JournalOrphanet journal of rare diseases (Orphanet J Rare Dis) Vol. 11 Issue 1 Pg. 79 (06 18 2016) ISSN: 1750-1172 [Electronic] England
PMID27317422 (Publication Type: Journal Article)
Chemical References
  • Nucleotidyltransferases
  • TRNT1 protein, human
Topics
  • Anemia, Sideroblastic (genetics, metabolism)
  • Blotting, Western
  • Cell Respiration (genetics, physiology)
  • Cells, Cultured
  • Female
  • Fibroblasts (metabolism)
  • Fluorescent Antibody Technique
  • Humans
  • Membrane Potential, Mitochondrial
  • Microscopy, Electron, Transmission
  • Mitochondria (metabolism)
  • Mutation
  • Nucleotidyltransferases (genetics, metabolism)
  • Oxidative Phosphorylation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: